Skip to content

Establishment and validation of a predictive model for hypoxemia in middle-aged and elderly outpatient patients undergoing painless gastroscopy diagnosis and treatment

Establishment and validation of a predictive model for hypoxemia in middle-aged and elderly outpatient patients undergoing painless gastroscopy diagnosis and treatment

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079686
Enrollment
Unknown
Registered
2024-01-09
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia

Interventions

Hypoxemia group/non hypoxemia group:none

Sponsors

The Second Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Outpatients undergoing painless gastroscopy for elective intravenous general anesthesia; 2. ASA level I-III; 3.50 years old = age = 85 years old, regardless of gender; 4. Clearly understand and voluntarily participate in this study, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who require complex endoscopic procedures for diagnosis and treatment (such as cholangiopancreatography, endoscopic ultrasonography, endoscopic mucosal resection, submucosal dissection, etc.) and patients who plan to undergo tracheal intubation; 2. Patients who have not been properly controlled and have merged with potentially life-threatening circulatory and respiratory diseases (such as uncontrolled severe hypertension, severe arrhythmia, unstable angina, acute respiratory infections, asthma episodes, etc.); 3. Patients with liver dysfunction (Child Pugh C or above), acute upper gastrointestinal bleeding with shock, severe anemia, gastrointestinal obstruction with gastric content retention; 4. Without accompanying or guardian; 5. Individuals with allergies to sedative/anesthetic drugs and other serious anesthesia risks; 6. Loss or inability to obtain important data and subject withdrawal.

Design outcomes

Primary

MeasureTime frame
pulse oximetry;drink;

Secondary

MeasureTime frame
age;sex;body mass index;merge underlying diseases;snore;smoke;difficult airway;electrocardiogram;ASA grade;anesthesia induction dose;duration of anesthesia induction;opioids;motion;cough;biopsy;addition anesthesia drugs;gastroscopy duration;

Countries

China

Contacts

Public ContactZheng Leilei

The Second Affiliated Hospital of Zunyi Medical University

zackzll@163.com+86 151 2120 6958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026